Tumor lysis syndrome occurring after the administration of rituximab for posttransplant lymphoproliferative disorder.
Francescone SA, Murphy B, Fallon JT, Hammond K, Pinney S. Tumor lysis syndrome occurring after the administration of rituximab for posttransplant lymphoproliferative disorder. Transplant Proc. 2009 Jun; 41(5):1946-8.